Synthekine

Menlo Park, CA · Founded 2018 · Privately Held (backing)

Developer of engineered cytokine therapeutics designed to facilitate disease-optimized treatments. Synthekine is based in Menlo Park, CA and was founded in 2018. Its last reported valuation was $500 million in Dec 2022. It has raised $289 million.

Last reported valuation

$500.0M

Oct 2026

Priced at

—

Total raised

$288.6M

Last round

—

How much has Synthekine raised?

$288.6Macross 0 recorded rounds

Free account

More of Synthekine with a free account

·The complete investor list: 13 names
·Watch Synthekine: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Synthekine investors

13 investors are on record for Synthekine, including RA Capital Management, Canaan Partners, Emerson Collective and Deerfield Management. By type, the record holds 5 venture capital firms, 1 hedge fund and 1 asset manager.

For fundraisers

Raising for a company like Synthekine?

13 investors have backed Synthekine.

See all 13 investors →

Frequently asked about Synthekine

How much has Synthekine raised?: Synthekine has raised $288.6M in total across 0 recorded funding rounds.